In addition, to assess the relationship between the clinicopathological features and expression level of SGO2, high and low expressions of SGO2 were grouped according to tumor grade, tumor stage and T stage, vascular invasion, and ECOG score (all p < 0.05; Figure 1D–H). This evidence concerns the gene SGO2 and neoplasm.